• Phosphoproteomic Adaptation to Cabozantinib in RCC

  2026-09-20

  This study distinguishes acute from chronic Cabozantinib exposure in renal cell carcinoma by integrating quantitative phosphoproteomics with migration and invasion assays. Its main contribution is a timescale-aware model in which broad cytostatic phosphorylation changes evolve into selective adhesion-, stress-, and MAPK/AP-1-associated remodeling while MET activation-loop phosphorylation remains suppressed.

• ATRA Sensitizes Ovarian Cancer to Niraparib

  2026-09-19

  The reference study shows that all-trans retinoic acid can reduce cisplatin-induced resistance to niraparib in epithelial ovarian cancer models. Its treatment-sequence findings connect retinoid signaling with suppression of an ALDH1A1–NAMPT–PARP1–CHK1 and NAD+-associated resistance state, supporting a maintenance strategy that combines ATRA with PARP inhibition.

• Silymarin Workflows for Translational Research

  2026-09-19

  Silymarin, a chemically diverse milk thistle extract, gives researchers a practical probe for oxidative injury, tumor biology, metabolic dysfunction, and selected antiviral target assays. This guide turns its solubility, mixture composition, and redox activity into controlled workflows with dose-selection, orthogonal validation, and troubleshooting strategies.

• Alpha-Ketoglutarate at the Tumor–Immune Interface

  2026-09-18

  A translational analysis of how α-KGA connects mitochondrial metabolism, PDHA1 succinylation, macrophage antigen presentation, and chemotherapy response in cholangiocarcinoma research.

• CSBTA Pharmacokinetics in MASH Mice

  2026-09-17

  This study shows that HFHCD-induced MASH changes the systemic exposure, hepatic distribution, and hepatocyte accumulation of key Corydalis saxicola Bunting total alkaloids. By combining UHPLC-MS/MS, transporter and microsomal assays, and analyses of CYP450s and PXR-related regulation, the work provides a disease-state framework for interpreting pharmacokinetic variability and optimizing future MASH dosing studies.

• GCRV Entry and Clathrin-Mediated Endocytosis

  2026-09-17

  Wang et al. used pharmacological inhibitors, transmission electron microscopy, and real-time qPCR to show that genotype III grass carp reovirus enters CIK cells through a dynamin-dependent, acidification-sensitive clathrin pathway. The study also provides an important negative control for IPA-3: under the tested conditions, Pak1-directed inhibition did not measurably block GCRV entry or infection.

• Fluconazole for Reproducible Fungal Assays

  2026-09-16

  This scenario-driven guide explains how Fluconazole, SKU B2094, can support controlled fungal viability, susceptibility, and resistance experiments. It connects mechanism, solvent handling, dose selection, storage, and interpretation to practical laboratory decisions.

• JC-1 Mitochondrial Membrane Potential Assay Kit

  2026-09-16

  Build a ratiometric mitochondrial membrane potential assay around JC-1, CCCP controls, and matched treatment conditions. This practical guide connects mitochondrial depolarization measurements with apoptosis studies of hypoxia-activated cancer therapeutics while emphasizing optimization, controls, and interpretation limits.

• MK-4827: Reframing PARP Inhibition for Translation

  2026-09-15

  A translational perspective on MK-4827 (Niraparib), connecting PARP-1/-2 inhibition, BRCA-associated synthetic lethality, and hyperthermia-induced BRCA2 loss to better experimental design and combination strategy.

• Novobiocin, DNA Replication, and E. faecalis Protoplasts

  2026-09-15

  This study shows that DNA replication is linked to plasma membrane synthesis and vacuole formation during enlargement of Enterococcus faecalis protoplasts. By applying novobiocin at defined stages and tracking DNA content, cell size, and vacuoles, the authors identify a reversible replication-dependent control point in bacterial morphogenesis.

• BicD and MAP7 Activate Drosophila Kinesin-1

  2026-09-14

  This 2025 bioRxiv preprint shows that BicD and MAP7 activate homodimeric Drosophila kinesin-1 through complementary mechanisms. BicD primarily relieves kinesin autoinhibition, whereas MAP7 promotes microtubule recruitment and longer runs, producing the strongest activation when both regulators are present.

• Smg5–Hnrnpl–Mag Control of Oligodendrocyte Maturation

  2026-09-14

  The reference study identifies an Smg5-dependent nonsense-mediated mRNA decay pathway that controls oligodendrocyte differentiation through selective regulation of Hnrnpl variant transcripts. Its findings connect RNA surveillance with HNRNPL-dependent alternative splicing of Mag and Nfasc, providing a mechanistic framework for understanding CNS myelination and its functional consequences.

• DOT1L Inhibition in Renal Fibrosis: Study Insights

  2026-09-13

  The reference study identifies DOT1L-dependent H3K79 methylation as a modifiable regulator of renal fibroblast activation and epithelial–mesenchymal transition after obstructive kidney injury. By combining a selective inhibitor, DOT1L silencing, cultured renal cells, and a murine unilateral ureteral obstruction model, it provides a mechanistic basis for investigating epigenetic control of renal fibrosis.

• InstaBlue Protein Stain Solution: Assay Design

  2026-09-12

  InstaBlue Protein Stain Solution can turn rapid gel staining into a more deliberate analytical decision point. This article connects Coomassie-based visualization with PRMT6-mediated antiviral research, clarifying what a stained gel can prove, what it cannot, and how to preserve samples for downstream analysis.

• Fast-Dissociating Antibodies from Hybridoma Cultures

  2026-09-12

  Miyoshi et al. developed a semi-automated single-molecule TIRF assay that identifies specific, fast-dissociating monoclonal antibodies directly from hybridoma cultures. The resulting Fab probes enabled multiplex super-resolution imaging and revealed rapid espin turnover within long-lived actin cores of inner-ear hair-cell stereocilia.

8540 records 1/570 page Next 12345 下5页 Last page